Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.21 is 74% above its 5-year average of -19.79, near the high end of its 5-year range (-40.52–-5.21).
79.23% above its 12-month average of -25.08.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.63.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
EARNINGS PER SHARE (EPS)
-5.21
EARNINGS PER SHARE (EPS) AVG TTM
-25.08
EARNINGS PER SHARE (EPS) AVG 3Y
-23.14
EARNINGS PER SHARE (EPS) AVG 5Y
-19.79
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+79.23%
CURRENT VS 3Y AVG
+77.48%
CURRENT VS 5Y AVG
+73.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
ImageneBio Inc
Market Cap
$51.66M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$53.46M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
Market Cap
$53.15M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.57
3Y Avg
-0.69
5Y Avg
-0.62
Market Cap
$52.78M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$52.60M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.08
3Y Avg
0.02
5Y Avg
0.04
Market Cap
$52.54M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$50.93M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$51.51M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImageneBio Inc (IMA) | $51.66M | -5.21 | -25.08 | -23.14 | -19.79 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.46M | -0.27 | -0.75 | -1.03 | -0.90 |
| Spectral AI, Inc. (MDAI)vs › | $53.15M | -0.35 | -0.57 | -0.69 | -0.62 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.78M | -1.00 | -1.43 | -2.38 | -2.90 |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A | -0.08 | 0.02 | 0.04 |
| Aldeyra The (ALDX)vs › | $52.54M | -0.39 | -0.75 | -0.80 | -0.90 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.93M | N/A | -7.29 | -67.66 | -178.24 |
| biote Corp. (BTMD)vs › | $51.83M | 0.12 | 0.48 | 0.24 | 1.52 |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | -1.20 | -0.91 | -0.56 | -0.48 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -8.95 | -8.42 | -12.89 | -25.33 |
Trailing EPS (TTM)
$-5.21
Forward EPS (Est.)
$-3.22
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -9.64 |
| 2024-12-31 | -40.52 |
| 2023-12-31 | -19.60 |
| 2022-12-31 | -22.80 |
| 2021-12-31 | -11.38 |
| 2020-12-31 | -14.81 |
| 2019-12-31 | -5.63 |
| 2018-12-31 | -13.68 |
